322 related articles for article (PubMed ID: 26206950)
41. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
Heck JE; Albert SM; Franco R; Gorin SS
J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
[TBL] [Abstract][Full Text] [Related]
42. Temporal trend in relative risk of second primary colorectal cancer.
Das A; Chak A; Cooper GS
Am J Gastroenterol; 2006 Jun; 101(6):1342-7. PubMed ID: 16771959
[TBL] [Abstract][Full Text] [Related]
43. Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
Wolff AC; Blackford AL; Visvanathan K; Rugo HS; Moy B; Goldstein LJ; Stockerl-Goldstein K; Neumayer L; Langbaum TS; Theriault RL; Hughes ME; Weeks JC; Karp JE
J Clin Oncol; 2015 Feb; 33(4):340-8. PubMed ID: 25534386
[TBL] [Abstract][Full Text] [Related]
44. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
Schrag D; Gelfand SE; Bach PB; Guillem J; Minsky BD; Begg CB
J Clin Oncol; 2001 Sep; 19(17):3712-8. PubMed ID: 11533092
[TBL] [Abstract][Full Text] [Related]
45. Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting.
McKibbin T; Frei CR; Greene RE; Kwan P; Simon J; Koeller JM
Oncologist; 2008 Aug; 13(8):876-85. PubMed ID: 18695260
[TBL] [Abstract][Full Text] [Related]
46. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.
Wong AC; Stock S; Schrag D; Kahn KL; Salz T; Charlton ME; Rogers SO; Goodman KA; Keating NL
J Oncol Pract; 2014 Sep; 10(5):e360-7. PubMed ID: 24986112
[TBL] [Abstract][Full Text] [Related]
47. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.
Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
[No Abstract] [Full Text] [Related]
48. Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
Siegel RL; Fedewa SA; Anderson WF; Miller KD; Ma J; Rosenberg PS; Jemal A
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376186
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population.
Kumar A; Shah N; Modi Y; Shaaban HS; DePasquale J; DeBari VA; Yerrabothala S; Maroules M; Guron GK
Med Oncol; 2012 Sep; 29(3):1773-9. PubMed ID: 21710235
[TBL] [Abstract][Full Text] [Related]
50. Secular trends in colon and rectal cancer relative survival.
Rutter CM; Johnson EA; Feuer EJ; Knudsen AB; Kuntz KM; Schrag D
J Natl Cancer Inst; 2013 Dec; 105(23):1806-13. PubMed ID: 24174654
[TBL] [Abstract][Full Text] [Related]
51. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
52. Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.
Fessele KL; Hayat MJ; Atkins RL
Oncol Nurs Forum; 2017 Sep; 44(5):E203-E212. PubMed ID: 28820513
[TBL] [Abstract][Full Text] [Related]
53. Initial treatment for newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States.
Gigli A; Warren JL; Yabroff KR; Francisci S; Stedman M; Guzzinati S; Giusti F; Miccinesi G; Crocetti E; Angiolini C; Mariotto A
J Natl Cancer Inst Monogr; 2013; 2013(46):88-98. PubMed ID: 23962512
[TBL] [Abstract][Full Text] [Related]
54. Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States.
Sanford NN; Ahn C; Beg MS; Sanjeevaiah A; Kazmi SA; Folkert MR; Aguilera TA; Sher DJ
Am J Clin Oncol; 2020 Jul; 43(7):526-530. PubMed ID: 32324600
[TBL] [Abstract][Full Text] [Related]
55. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.
Tong L; Ahn C; Symanski E; Lai D; Du XL
Ann Oncol; 2014 Jun; 25(6):1234-42. PubMed ID: 24681607
[TBL] [Abstract][Full Text] [Related]
56. Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.
Zafar SY; Abernethy AP; Abbott DH; Grambow SC; Marcello JE; Herndon JE; Rowe KL; Kolimaga JT; Zullig LL; Patwardhan MB; Provenzale DT
BMC Cancer; 2008 Nov; 8():345. PubMed ID: 19032772
[TBL] [Abstract][Full Text] [Related]
57. Using Literature Review and Structured Hybrid Electronic/ Manual Mortality Review to Identify System-Level Improvement Opportunities to Reduce Colorectal Cancer Mortality.
Schottinger JE; Kanter MH; Litman KC; Lau H; Schwartz GE; Brasfield FM; Alshak NS; Difronzo LA
Jt Comm J Qual Patient Saf; 2016 Jul; 42(7):303-10. PubMed ID: 27301833
[TBL] [Abstract][Full Text] [Related]
58. Unemployment risk at 2 and 4 years following colorectal cancer diagnosis: a population based study.
Rottenberg Y; Ratzon NZ; Cohen M; Hubert A; Uziely B; de Boer AG
Eur J Cancer; 2016 Dec; 69():70-76. PubMed ID: 27821321
[TBL] [Abstract][Full Text] [Related]
59. Predictors of guideline treatment nonadherence and the impact on survival in patients with colorectal cancer.
Hines RB; Barrett A; Twumasi-Ankrah P; Broccoli D; Engelman KK; Baranda J; Ablah EA; Jacobson L; Redmond M; Tu W; Collins TC
J Natl Compr Canc Netw; 2015 Jan; 13(1):51-60. PubMed ID: 25583769
[TBL] [Abstract][Full Text] [Related]
60. Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
Sanford NN; Folkert MR; Aguilera TA; Beg MS; Kazmi SA; Sanjeevaiah A; Zeh HJ; Farkas L
Am J Clin Oncol; 2020 Dec; 43(12):850-856. PubMed ID: 32976176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
